This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Strober, J. B. Articles by Tennekoon, G. I. Search for Related Content PubMed PubMed Citation Articles by Strober, J. B. Articles by Tennekoon, G. I. Social Bookmarking                   What's this?

Topical Review: Progressive Spinal Muscular Atrophies

Department of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, jstrobe{at}emory.edu

Gihan I. Tennekoon, MD

Department of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA

Spinal muscular atrophy is the most common autosomal-recessive genetic disorder lethal to infants. It was first described in the 1890s. Since then our understanding of the disorder has progressed significantly. Progression of the disease is due to loss of anterior horn cells, thought to be caused by apoptosis. Diagnosis is based on the course of the illness, as well as certain changes seen on nerve and muscle biopsy and electrodiagnostic studies. More recently, our understanding of the genetics of this disorder has provided a noninvasive approach to diagnosis. This method of testing has its downside, but the quest for a more sensitive analysis is still underway. Even though our knowledge of this disease has come a long way since its first recognition, the therapies available to these children are still only supportive. Again, researchers eagerly look for new therapeutic interventions to allow for improved quality of life and an extended life span. (J Child Neurol 1999;14:691-695).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?